Skip to Main Content

Cost-Effectiveness of a Policy Strategy to Decrease Sodium Intake: Global Analysis

2017

The objective of this study was to assess the cost effectiveness of a government policy combining targeted industry agreements and public education to reduce sodium intake in 183 countries worldwide. To account for heterogeneity in efficacy across countries, a range of scenarios were evaluated, including 10%, 30%, 0.5 g/day, and 1.5 g/day sodium reductions achieved over 10 years.

Country specific costs of a sodium reduction policy were estimated using the WHO Noncommunicable Disease Costing Tool. Country specific impacts on mortality and disability adjusted life years (DALYs) were modeled using comparative risk assessment. No potential healthcare savings from prevented events were included.

Worldwide, a 10% reduction in sodium consumption over 10 years within each country was projected to avert approximately 5.8 million DALYs/year related to cardiovascular diseases, at a population weighted mean cost of I$1.13 per capita over the 10 year intervention. The population weighted mean cost effectiveness ratio was approximately I$204/DALY. Across nine world regions, estimated cost effectiveness of sodium reduction was best in South Asia (I$116/DALY). Most (96.0%) of the world’s adult population lived in countries in which this intervention had a cost effectiveness ratio <0.1×GDP per capita, and 99.6% in countries with a cost effectiveness ratio <1.0×GDP per capita.

 

Source:

Webb M, Fahimi S, Singh GM et al. Cost Effectiveness of a Government Supported Policy Strategy to Decrease Sodium Intake: Global Analysis Across 183 Nations. BMJ 2017; 356. https://doi.org/10.1136/bmj.i6699